A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas : A Spanish group for sarcoma research (GEIS) retrospective study

Altres ajuts: PharmaMar S.A. The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. A retrospective series of 357 pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Martínez-Trufero, Javier, Sande-González, Luis Miguel de, Luna, Pablo, Martín-Broto, Javier, Alvarez, Rosa, Marquina, Gloria, Diaz-Beveridge, Roberto, Poveda, Andrés, Cano, Juana María, Cruz-Jurado, Josefina, López Pousa, Antonio, Salgado, María Angeles Vaz, Valverde-Morales, Claudia Maria, Sevilla, Isabel, Martínez-García, Jerónimo, Rubio-Casadevall, Jordi, Juan, Ana de, Carrasco, Juan Antonio, Moura, David S, Gurruchaga-Sotes, Ibon, Gutiérrez, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	GEISTRA Growth modulation index L-sarcoma Prognostic score Sarcoma Trabectedin
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!